CHEK 1 (-7.41%)
IL0011336851• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. CHEK

Check-Cap (CHEK) Competitor Comparison

We are evaluating the key criteria listed to compare Check-Cap (CHEK) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 56

Dividend yield

0 / 9

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Performance 10 years - CHEK ranking 0 / 58

These are the competitors of Check-Cap in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.33K
3. Medpace Holdings MEDP
1.19K
4. RadNet RDNT
791.03
5. Natera NTRA
645.06
6. IDEXX Laboratories IDXX
494.55
7. DexCom DXCM
450.87
8. Thermo Fisher Scientific TMO
373.92
9. Mettler-Toledo MTD
372.08
10. Danaher DHR
349.76
11. Icon ICLR
309.31
12. CareDx CDNA
280.23
13. IQVIA Holdings IQV
280.08
14. Twist Bioscience TWST
249.23
15. PerkinElmer PKI
247.07
16. Waters WAT
245.41
17. Charles River Laboratories CRL
239.09
18. Agilent Technologies A
233.53
19. NeoGenomics NEO
224.49
20. Laboratory Corp of America Holdings LH
179.54
21. Quest Diagnostics DGX
157.92
22. Exact Sciences EXAS
124.8
23. Syneos Health SYNH
113.83
24. Fulgent Genetics FLGT
110.97
25. Qiagen QGEN
78.83
26. Meridian Bioscience VIVO
60.69
27. Inotiv NOTV
28.21
28. National Research NRC
17.66
29. Ortho Clinical Diagnostics Holdings OCDX
13.74
30. Guardant Health GH
3.1
31. Neogen NEOG
0.44
32. Illumina ILMN
-16.65
33. Bioventus BVS
-21.72
34. Olink Holding OLK
-26.82
35. Anixa Biosciences ANIX
-31.2
36. Sotera Health SHC
-40.41
37. Myriad Genetics MYGN
-48.49
38. Sera Prognostics SERA
-55.1
39. Pacific Biosciences of California PACB
-64.78
40. Global Cord Blood CO
-66.57
41. DarioHealth DRIO
-75.47
42. Enzo Biochem ENZ
-76.58
43. MaxCyte MXCT
-80.11
44. Personalis PSNL
-80.72
45. Co-Diagnostics CODX
-81
46. Exagen XGN
-83.04
47. MDxHealth MDXH
-83.29
48. bioAffinity Technologies BIAF
-83.69
49. Psychemedics PMD
-84.33
50. Biodesix BDSX
-89.92
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-96.16
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Interpace Biosciences IDXG
-97.88
56. Trinity Biotech TRIB
-98.14
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.77
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.